Blog
Blog
Addressing the challenges of packaging OSD and powder products with low humidity and/or low oxygen requirements.
The pharmaceutical industry must live by the rules of the regulatory bodies such as the FDA, EMEA, and other organizations. In the US Code…
Continue Reading
Blog
Trends in global drug supply: An interview with Sharp President, Kevin Orfan
On the Molecule to Market podcast, Sharp president Kevin Orfan discusses the importance of building robust and scalable systems and processes in a fast-growing…
Continue Reading
Blog
Clinical Trial & Commercial Packaging Trends & Predictions
Perhaps more than any other industry, pharma and biotech have undergone radical change in 2020 as a result of the COVID-19 pandemic. From supply…
Continue Reading
Blog
Need for speed: the key to successful multi-market product launches
Launching a new drug in the European marketplace presents a variety of unique challenges. Numerous official working languages, complex independent regulatory requirements combined with an overarching framework, and the intricacy and scale of distribution are all characteristics of an EU launch.
Continue Reading
Blog
Low-volume / small-batch packaging challenges (in both the US and EU)
Meeting the small-batch pharma packaging challenge Medications are becoming far more specialized and personalized and these specialty drug products continue to emerge as the…
Continue Reading
Blog
Supporting the rapid launch of pharmaceutical and biopharma products: a contract packaging perspective
Product launches see pharma and biotech companies handing over drugs with incredible value, both commercially and to the health of patients globally, to contract…
Continue Reading